Vale SA vs Health Care Select Sector SPDR Fund — how do they compare? Vale SA trades at $15.41 (market cap $66.16B), while Health Care Select Sector SPDR Fund trades at $167.05. The key difference: Vale SA pays a 7.71% dividend while Health Care Select Sector SPDR Fund pays none, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Vale SA nearer its low. Which is the better fit depends on your goals.
| VALE | XLV | |
|---|---|---|
Market Cap | $66.16B | — |
Sector | Basic Materials | — |
52-Week High | $17.82 | $175.68 |
52-Week Low | $10.50 | $134.13 |
Enterprise Value | $82.41B | — |
Dividend Yield | 7.71% | — |
Signals from Pluang's Aura AI — not financial advice
VALE trades at $15.56, up 1.9% today, with a bullish technical signal and mixed fundamentals. Recent earnings missed estimates, but cash flow improved to $2.42B in 2025. The company maintains a stable dividend and sees iron ore demand as resilient, per CFO comments on September 9, 2026.
Outlook is cautious due to declining profit margins and rising debt, but analyst consensus suggests modest upside to a $16.25 price target. Risks include commodity price volatility and operational costs, while institutional interest remains steady.
XLV trades at $167.16, down 2.5% amid testing key support levels, with technical indicators showing mixed signals between bullish moving averages and bearish oscillators. The healthcare ETF maintains defensive appeal with upcoming dividend payments and sector rotation benefits during potential Fed tightening. Recent options activity shows increased put volume, suggesting some near-term caution among traders.
Healthcare sector strength and defensive positioning support XLV's long-term outlook, though near-term technical weakness and sector-specific headwinds from failed drug trials present risks. The ETF's low expense ratio and diversified healthcare exposure provide stability, with earnings momentum and FDA approvals driving fundamental strength.
Trailing returns across standard periods
Vale is the world's largest iron ore miner and one of the largest diversified miners, along with BHP and Rio Tinto. Earnings are dominated by the bulk materials division, primarily iron ore and iron ore pellets, with minor contributions from iron ore proxies, including manganese and coal. The base metals division is much smaller, primarily consisting of nickel mines and smelters with a small contribution from copper.
Read more on VALE →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →